|

Gastroparesis Registry 4

RECRUITINGSponsored by Johns Hopkins Bloomberg School of Public Health
Actively Recruiting
SponsorJohns Hopkins Bloomberg School of Public Health
Started2024-09-20
Est. completion2027-04-30
Eligibility
Age18 Years – 85 Years
Healthy vol.Accepted
Locations6 sites

Summary

The Gastroparesis Registry 4 (GpR4) is an observational study of patients with symptoms of gastroparesis (Gp) and functional dyspepsia (FD) with either delayed or normal gastric emptying. To better understand these disorders, this registry will capture demographic, clinical, physiological, questionnaire, and patient outcome data to characterize the patients and their clinical course. Participants will complete several questionnaires, complete a nutrient drink test and have a gastric emptying study.

Eligibility

Age: 18 Years – 85 YearsHealthy volunteers accepted
Inclusion Criteria:

* Age at least 18 years at initial screening visit
* Symptoms of Gp and/or FD of at least 12-weeks duration with varying degrees of nausea, vomiting, early satiety, postprandial fullness, abdominal pain, abdominal burning. Thus, patients can enter the GpR4 registry primarily with abdominal pain suggesting FD-Epigastric Pain Syndrome.
* Successful completion of gastric emptying scintigraphy of solids using the 4-hour Egg Beaters® protocol (or equivalent generic liquid egg white meal) within the last 9 months
* Negative upper endoscopy or upper radiographic GI series within 5 years of registration

Exclusion Criteria:

* Use of narcotic analgesics greater than three days per week
* Presence of other conditions that could explain the patient's symptoms such as:
* Pyloric or intestinal obstruction as evidenced by EGD, UGI, or Abdominal CT
* Active inflammatory bowel disease
* Known eosinophilic gastroenteritis or eosinophilic esophagitis
* Primary neurological conditions that can cause nausea and vomiting such as increased intracranial pressure, space occupying or inflammatory/infectious lesions
* Acute or chronic renal failure (serum creatinine \>3 mg/dL) and/or on hemodialysis or peritoneal dialysis
* Acute liver failure or advanced liver disease (Child's B or C; a Child-Pugh-Turcotte (CPT) score of ≥7)
* Pancreatic disorder if present on pancreatic imaging or pancreatic function testing
* Prior gastric surgery including total or subtotal (near complete) gastric resection, esophagectomy, gastrojejunostomy, gastric bypass, gastric sleeve, pyloroplasty, pyloromyotomy, or any fundoplication (Nissen, Tor)
* Any other condition, which in the opinion of the investigator, could explain the symptoms or interfere with study requirements
* Females who are pregnant. A urine pregnancy test is routinely obtained on all females immediately prior to gastric emptying procedures.
* Inability to comply with or complete the gastric emptying scintigraphy test (including allergy to eggs)
* Inability to obtain informed consent

Conditions7

DiabetesFunctional Disorder of Gastrointestinal TractGastro-Intestinal DisorderGastroparesisGastroparesis Due to Diabetes Mellitus Type IGastroparesis Due to Diabetes Mellitus Type IIGastroparesis Nondiabetic

Locations6 sites

Jay Pasricha
Scottsdale, Arizona, 85259
Jay Pasricha, MDpasricha.jay@mayo.org
University of Louisville
Louisville, Kentucky, 40202
Thomas Abell, MD502-852-7963thomas.abell@louisville.edu
Massachusetts General Hospital
Boston, Massachusetts, 02114
Braden L Kuo, MD617-726-0196bkuo@partners.org
Wake Forest University and Atrium Health Carolinas Medical Center
Charlotte, North Carolina, 28202
Baha Moshiree, MD704-355-4593
Temple University Hospital
Philadelphia, Pennsylvania, 19140
Henry Parkman, MD215-707-7579henry.parkman@temple.edu

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.